American Heart Journal
Volume 151, Issue 5 , Pages 992-998 , May 2006

Multifaceted intervention to promote β-blocker use in heart failure

Received 1 February 2005 ,Accepted 15 June 2005.

References 

  1. CIBIS-II Investigators and Committees . The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet. 1999;353:9–13
  2. MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet. 1999;353:2001–2007
  3. Bristow MR, Gilbert EM, Abraham WT, et al. Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators. Circulation. 1996;94:2807–2816
  4. Colucci WS, Packer M, Bristow MR, et al. Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. US Carvedilol Heart Failure Study Group. Circulation. 1996;94:2800–2806
  5. Packer M, Bristow MR, Cohn JN, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. US Carvedilol Heart Failure Study Group. N Engl J Med. 1996;334:1349–1355
  6. Heart Failure Society of America. Heart Failure Society of America (HFSA) practice guidelines. HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction—pharmacological approaches. J Card Fail. 1999;5:357–382
  7. Hunt SA, Baker DW, Chin MH, et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee to revise the 195 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol. 2001;38:2101–2113
  8. Frohlich ED. Left ventricular hypertrophy, cardiac diseases and hypertension: recent experiences. J Am Coll Cardiol. 1989;14:1587–1594
  9. Hurst JW. In: The heart. New York: McGraw Hill; 1990;p. 1727
  10. Cabana MD, Rand CS, Powe NR, et al. Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA. 1999;282:1458–1465
  11. Veatch RM. Reasons physicians do not follow clinical practice guidelines. JAMA. 2000;283:1685
  12. Carruthers SG. Assimilating new therapeutic interventions into clinical practice: how does hypertension compare with other therapeutic areas?. Am Heart J. 1999;138:256–260
  13. Wolfinger RD, O'Connell M. Generalized linear mixed models: a pseudo-likelihood approach. J Stat Comput Simul. 1993;48:233–243
  14. Gruber JL. Strategies for implementing quantifiable group practice guidelines. J Healthc Qual. 1999;21:11–20
  15. Hulscher ME, van Drenth BB, Mokkink HG, et al. Tailored outreach visits as a method for implementing guidelines and improving preventive care. Int J Qual Health Care. 1998;10:105–112
  16. Mehta RH, Montoye CK, Gallogly M, et al. Improving quality of care for acute myocardial infarction: the Guidelines Applied in Practice (GAP) Initiative. JAMA. 2002;287:1269–1276
  17. Pathman DE, Konrad TR, Freed GL, et al. The awareness-to-adherence model of the steps to clinical guideline compliance. The case of pediatric vaccine recommendations. Med Care. 1996;34:873–889
  18. Simpson RJ, Sueta CA, Boccuzzi SJ, et al. Performance assessment model for guideline-recommended pharmacotherapy in the secondary prevention of coronary artery disease and treatment of left ventricular dysfunction. Am J Cardiol. 1997;80:53H–56H
  19. Soumerai SB, McLaughlin TJ, Gurwitz JH, et al. Effect of local medical opinion leaders on quality of care for acute myocardial infarction: a randomized controlled trial. JAMA. 1998;279:1358–1363
  20. Tierney WM, Overhage JM, Murray MD, et al. Effects of computerized guidelines for managing heart disease in primary care. J Gen Intern Med. 2003;18:967–976
  21. Weingarten SR, Henning JM, Badamgarav E, et al. Interventions used in disease management programmes for patients with chronic illness—which ones work? Meta-analysis of published reports. BMJ. 2002;325:925
  22. Bertoni AG, Duren-Winfield V, Ambrosius WT, et al. Quality of heart failure care in managed Medicare and Medicaid patients in North Carolina. Am J Cardiol. 2004;93:714–718
  23. Gupta R, Tang WH, Young JB. Patterns of beta-blocker utilization in patients with chronic heart failure: experience from a specialized outpatient heart failure clinic. Am Heart J. 2004;147:79–83
  24. Whellan DJ, Gaulden L, Gattis WA, et al. The benefit of implementing a heart failure disease management program. Arch Intern Med. 2001;161:2223–2228
  25. Kramer J, Chen A, Hammill B, et al. Time trends and factors associated with outpatient beta-blocker use in patients with heart failure or left ventricular dysfunction. Circulation. 2004;109:e266
  26. Phillips CO, Wright SM, Kern DE, et al. Comprehensive discharge planning with postdischarge support for older patients with congestive heart failure: a meta-analysis. JAMA. 2004;291:1358–1367
  27. Ansari M, Shlipak MG, Heidenreich PA, et al. Improving guideline adherence: a randomized trial evaluating strategies to increase beta-blocker use in heart failure. Circulation. 2003;107:2799–2804

 This study was presented at the American College of Cardiology Annual Scientific Session 2004, New Orleans, La, March 10, 2004.

PII: S0002-8703(05)00655-1

doi: 10.1016/j.ahj.2005.06.038

American Heart Journal
Volume 151, Issue 5 , Pages 992-998 , May 2006

Article Tools

* Image Usage & Resolution